Hari Pujar, Ph.D., Operating Partner at Flagship Pioneering, addresses future of new modalities at AAPS National Biotechnology Conference
Hari Pujar, Ph.D., Operating partner at Flagship Pioneering and Chief Operating Officer at Tessera Therapeutics, will present the opening plenary at the AAPS National Biotechnology Conference (NBC), Monday May 13, at 3 p.m PT, in San Francisco, CA.
His talk will explore what he calls the ‘explonential march upward’ in the biotechnology industry. Dr Pujar will also discuss the new technologies that Flagship Pioneering, the bioplatform innovation company, is currently building, in particular, Tessera Therapeutics and its Gene Writing™ technology, which offers a new approach to genome engineering.
“It is an honor to have Dr Pujar open this year’s NBC”, AAPS 2024 Scientific Programming Committee Chair Katie Maass, Ph.D., said “His talk will highlight the innovations happening in biotech and a look at the transformative technologies that will drive future innovation.”
“Dr. Pujar truly has his finger on the pulse of the biotechnology industry,” 2024 AAPS President Gopi Shankar, Ph.D., M.B.A., FAAPS said “He offers an optimistic view of the future of our industry and the new modalities that will lead to successful treatments.”
The NBC takes place May 13-16 at the Hilton San Francisco Union Square. To learn more and to register, visit www.aaps.org/nbc.
About AAPS ggg
American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online. www.aaps.org
The AAPS National Biotechnology Conference (NBC) uncovers the latest science and trends that impact today’s research and pharmaceutical markets, specifically in the areas of biologics, biotechnology products and advanced therapies. www.aaps.org/nbc
